339nok
4,0 %
Date:2025-06-30Time:18:00:00Latest report:Q4-2024List:Oslo GrowthTicker:ABS
Market Cap:91 mnokEnterprise Value:109 mnokNet Sales:43,5 mnokEarnings:-47,9 mnokEmployees:0ISIN:NO0010859580
Ratios
10-year key figure history for Arctic Bioscience turnover, profit, dividend, equity, PE and PB.
Stockprice
Price movement for Arctic Bioscience with index and moving average MA50 and MA200.
Stockprice:3,39
MA50:3,50
MA200:4,39
Price/MA200:-22,8 %
RSI (14):52,9
Price/MA50:-3,0 %
Description
Arctic Bioscience is a biotechnology company that develops and commercializes pharmaceutical products and dietary supplements based on bioactive marine raw materials. The company is developing HRO350, a new drug candidate for the treatment of patients with mild-to-moderate psoriasis. Their dietary supplements are sold globally both as bulk ingredients and as finished products under the ROMEGA brand, to both corporate and private customers.